{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:50:16Z","timestamp":1782100216375,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["43013117"],"award-info":[{"award-number":["43013117"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12010-026-05646-5","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:50:58Z","timestamp":1777013458000},"page":"5482-5507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunotherapy Treatment of Colorectal Cancer and Lung Metastasis with Genetically Modified Outer Membrane Vesicles Delivering Poly-Neoepitopes in a Mouse Model"],"prefix":"10.1007","volume":"198","author":[{"given":"Elham","family":"Sharif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Nematollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4653-7375","authenticated-orcid":false,"given":"Elham","family":"Mohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"5646_CR1","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/cancers16081530","volume":"16","author":"G Roshandel","year":"2024","unstructured":"Roshandel, G., Ghasemi-Kebria, F., & Malekzadeh, R. (2024). Colorectal Cancer: Epidemiology, Risk Factors, and Prevention. Cancers, 16, 1530.","journal-title":"Cancers"},{"key":"5646_CR2","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3390\/pharmaceutics15071969","volume":"15","author":"E Martinis","year":"2023","unstructured":"Martinis, E., Ricci, C., Trevisan, C., Tomadini, G., & Tonon, S. (2023). Cancer Vaccines: From the State of the Art to the Most Promising Frontiers in the Treatment of Colorectal Cancer. Pharmaceutics, 15, 1969.","journal-title":"Pharmaceutics"},{"key":"5646_CR3","doi-asserted-by":"publisher","unstructured":"Jia, W., Zhang, T., Huang, H., Feng, H., Wang, S., Guo, Z., Luo, Z., Ji, X., Cheng, X., & Zhao, R. (2022). Colorectal cancer vaccines: The current scenario and future prospects. Frontiers in Immunology, 13. https:\/\/doi.org\/10.3389\/fimmu.2022.942235","DOI":"10.3389\/fimmu.2022.942235"},{"key":"5646_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s43556-024-00222-x","volume":"5","author":"IN Weerarathna","year":"2024","unstructured":"Weerarathna, I. N., Doelakeh, E. S., Kiwanuka, L., Kumar, P., & Arora, S. (2024). Prophylactic and therapeutic vaccine development: advancements and challenges. Molecular Biomedicine, 5, 57. https:\/\/doi.org\/10.1186\/s43556-024-00222-x","journal-title":"Molecular Biomedicine"},{"key":"5646_CR5","doi-asserted-by":"publisher","first-page":"8270305","DOI":"10.1155\/2022\/8270305","volume":"2022","author":"Y Zheng","year":"2022","unstructured":"Zheng, Y., Fu, Y., Wang, P. P., & Ding, Z. Y. (2022). Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer. Disease Markers, 2022, 8270305. https:\/\/doi.org\/10.1155\/2022\/8270305","journal-title":"Disease Markers"},{"key":"5646_CR6","doi-asserted-by":"publisher","unstructured":"Ashi, M. O., Mami-Chouaib, F., & Corgnac, S. (2022). Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises, Exploration of targeted anti-tumor therapy 3 746\u2013762. https:\/\/doi.org\/10.37349\/etat.2022.00111","DOI":"10.37349\/etat.2022.00111"},{"key":"5646_CR7","doi-asserted-by":"publisher","unstructured":"Biswas, N., Chakrabarti, S., Padul, V., Jones, L. D., & Ashili, S. (2023). Designing neoantigen cancer vaccines, trials, and outcomes. Frontiers in Immunology, 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1105420","DOI":"10.3389\/fimmu.2023.1105420"},{"key":"5646_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/14712598.2024.2341744","volume":"24","author":"W Jia","year":"2024","unstructured":"Jia, W., Shen, X., Guo, Z., Cheng, X., & Zhao, R. (2024). The future of cancer vaccines against colorectal cancer. Expert Opinion on Biological Therapy, 24, 269\u2013284. https:\/\/doi.org\/10.1080\/14712598.2024.2341744","journal-title":"Expert Opinion on Biological Therapy"},{"key":"5646_CR9","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1158\/1078","volume":"22","author":"\u00d6 T\u00fcreci","year":"2016","unstructured":"T\u00fcreci, \u00d6., Vormehr, M., Diken, M., Kreiter, S., Huber, C., & Sahin, U. (2016). Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines. Clinical Cancer Research, 22, 1885\u20131896. https:\/\/doi.org\/10.1158\/1078","journal-title":"Clinical Cancer Research"},{"key":"5646_CR10","doi-asserted-by":"publisher","unstructured":"Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., Zhang, W., Luoma, A., Giobbie-Hurder, A., Peter, L., Chen, C., Olive, O., Carter, T. A., Li, S., Lieb, D. J., Eisenhaure, T., Gjini, E., Stevens, J., Lane, W. J., Javeri, I., Nellaiappan, K., Salazar, A. M., Daley, H., Seaman, M., Buchbinder, E. I., Yoon, C. H., Harden, M., Lennon, N., Gabriel, S., Rodig, S. J., Barouch, D. H., Aster, J. C., Getz, G., Wucherpfennig, K., Neuberg, D., Ritz, J., Lander, E. S., Fritsch, E. F., Hacohen, N., C.J., & Wu (2017). An immunogenic personal neoantigen vaccine for patients with melanoma, Nature 547 217\u2013221. https:\/\/doi.org\/10.1038\/nature22991","DOI":"10.1038\/nature22991"},{"key":"5646_CR11","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00262-023-03386-7","volume":"72","author":"YJ Yu","year":"2023","unstructured":"Yu, Y. J., Shan, N., Li, L. Y., Zhu, Y. S., Lin, L. M., Mao, C. C., Hu, T. T., Xue, X. Y., Su, X. P., Shen, X., & Cai, Z. Z. (2023). Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer, Cancer Immunology. Immunotherapy, 72, 2045\u20132056. https:\/\/doi.org\/10.1007\/s00262-023-03386-7","journal-title":"Immunotherapy"},{"key":"5646_CR12","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.3748\/wjg.v24.i48.5418","volume":"24","author":"S Wagner","year":"2018","unstructured":"Wagner, S., Mullins, C. S., & Linnebacher, M. (2018). Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens. World journal of gastroenterology, 24, 5418.","journal-title":"World journal of gastroenterology"},{"key":"5646_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-024-04971-x","author":"E Sharif","year":"2024","unstructured":"Sharif, E., Nezafat, N., Ahmadi, F. M., & Mohit, E. (2024). In Silico Design of CT26 Polytope and its Surface Display by ClearColi\u2122-Derived Outer Membrane Vesicles as a Cancer Vaccine Candidate Against Colon Carcinoma. Applied Biochemistry and Biotechnology. https:\/\/doi.org\/10.1007\/s12010-024-04971-x","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"5646_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s11033-021-06727-w","volume":"49","author":"Z Movahed","year":"2022","unstructured":"Movahed, Z., Sharif, E., Ahmadzadeh, M., Nezafat, N., Jahandar, H., & Mohit, E. (2022). Different strategies for expression and purification of the CT26-poly-neoepitopes vaccine in Escherichia coli. Molecular Biology Reports, 49, 859\u2013873. https:\/\/doi.org\/10.1007\/s11033-021-06727-w","journal-title":"Molecular Biology Reports"},{"key":"5646_CR15","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3390\/ijms20143403","volume":"20","author":"S Jiang","year":"2019","unstructured":"Jiang, S., Good, D., & Wei, M. Q. (2019). Vaccinations for Colorectal Cancer: Progress, Strategies, and Novel Adjuvants. International Journal of Molecular Sciences, 20, 3403.","journal-title":"International Journal of Molecular Sciences"},{"key":"5646_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","volume":"20","author":"B Pulendran","year":"2021","unstructured":"Pulendran, B., Arunachalam, P. S., & O\u2019Hagan, D. T. (2021). Emerging concepts in the science of vaccine adjuvants. Nature Reviews Drug Discovery, 20, 454\u2013475. https:\/\/doi.org\/10.1038\/s41573-021-00163-y","journal-title":"Nature Reviews Drug Discovery"},{"key":"5646_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41563-018-0028-2","volume":"17","author":"AW Li","year":"2018","unstructured":"Li, A. W., Sobral, M. C., Badrinath, S., Choi, Y., Graveline, A., Stafford, A. G., Weaver, J. C., Dellacherie, M. O., Shih, T. Y., & Ali, O. A. (2018). A facile approach to enhance antigen response for personalized cancer vaccination. Nature materials, 17, 528\u2013534.","journal-title":"Nature materials"},{"key":"5646_CR18","doi-asserted-by":"publisher","first-page":"16698","DOI":"10.1021\/acsnano.0c03776","volume":"14","author":"Y Li","year":"2020","unstructured":"Li, Y., Zhao, R., Cheng, K., Zhang, K., Wang, Y., Zhang, Y., Li, Y., Liu, G., Xu, J., & Xu, J. (2020). Bacterial outer membrane vesicles presenting programmed death 1 for improved cancer immunotherapy via immune activation and checkpoint inhibition. ACS nano, 14, 16698\u201316711.","journal-title":"ACS nano"},{"key":"5646_CR19","doi-asserted-by":"publisher","first-page":"1270158","DOI":"10.3389\/fmicb.2023.1270158","volume":"14","author":"R Meng","year":"2023","unstructured":"Meng, R., Zeng, M., Ji, Y., Huang, X., & Xu, M. (2023). The potential role of gut microbiota outer membrane vesicles in colorectal cancer. Frontiers In Microbiology, 14, 1270158. https:\/\/doi.org\/10.3389\/fmicb.2023.1270158","journal-title":"Frontiers In Microbiology"},{"issue":"9","key":"5646_CR20","doi-asserted-by":"publisher","first-page":"e12120","DOI":"10.1002\/jev2.12120","volume":"10","author":"KS Park","year":"2021","unstructured":"Park, K. S., Svennerholm, K., Crescitelli, R., L\u00e4sser, C., Gribonika, I., & L\u00f6tvall, J. (2021). Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy. Journal of Extracellular Vesicles, 10(9), e12120. https:\/\/doi.org\/10.1002\/jev2.12120","journal-title":"Journal of Extracellular Vesicles"},{"key":"5646_CR21","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1038\/s41596-022-00713-7","volume":"17","author":"X Zhao","year":"2022","unstructured":"Zhao, X., Zhao, R., & Nie, G. (2022). Nanocarriers based on bacterial membrane materials for cancer vaccine delivery. Nature Protocols, 17, 2240\u20132274. https:\/\/doi.org\/10.1038\/s41596-022-00713-7","journal-title":"Nature Protocols"},{"key":"5646_CR22","doi-asserted-by":"publisher","first-page":"8542","DOI":"10.3390\/ijms24108542","volume":"24","author":"AAQ Ahmed","year":"2023","unstructured":"Ahmed, A. A. Q., Besio, R., Xiao, L., & Forlino, A. (2023). Outer membrane vesicles (OMVs) as biomedical tools and their relevance as immune-modulating agents against H. pylori infections: current status and future prospects. International Journal of Molecular Sciences, 24, 8542.","journal-title":"International Journal of Molecular Sciences"},{"key":"5646_CR23","doi-asserted-by":"publisher","first-page":"987419","DOI":"10.3389\/fimmu.2022.987419","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang, S., Guo, J., Bai, Y., Sun, C., Wu, Y., Liu, Z., Liu, X., Wang, Y., Wang, Z., & Zhang, Y. (2022). Bacterial outer membrane vesicles as a candidate tumor vaccine platform. Frontiers in Immunology, 13, 987419.","journal-title":"Frontiers in Immunology"},{"key":"5646_CR24","doi-asserted-by":"publisher","first-page":"106440","DOI":"10.1016\/j.micpath.2023.106440","volume":"185","author":"L Sadeghi","year":"2023","unstructured":"Sadeghi, L., Mohit, E., Moallemi, S., Ahmadi, F. M., & Bolhassani, A. (2023). Recent advances in various bio-applications of bacteria-derived outer membrane vesicles. Microbial Pathogenesis, 185, 106440.","journal-title":"Microbial Pathogenesis"},{"key":"5646_CR25","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.20892\/j.issn.2095-3941.2022.0452","volume":"19","author":"X Gao","year":"2022","unstructured":"Gao, X., Feng, Q., Wang, J., & Zhao, X. (2022). Bacterial outer membrane vesicle-based cancer nanovaccines. Cancer biology & medicine, 19, 1290\u20131300.","journal-title":"Cancer biology & medicine"},{"key":"5646_CR26","doi-asserted-by":"publisher","unstructured":"Cheng, K., Zhao, R., Li, Y., Qi, Y., Wang, Y., Zhang, Y., Qin, H., Qin, Y., Chen, L., Li, C., Liang, J., Li, Y., Xu, J., Han, X., Anderson, G. J., Shi, J., Ren, L., Zhao, X., & Nie, G. (2021). Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology, Nature Communications 12 2041. https:\/\/doi.org\/10.1038\/s41467-021-22308-8","DOI":"10.1038\/s41467-021-22308-8"},{"key":"5646_CR27","doi-asserted-by":"crossref","unstructured":"Mamat, U., Woodard, R. W., Wilke, K., Souvignier, C., Mead, D., Steinmetz, E., Terry, K., Kovacich, C., Zegers, A., & Knox, C. (2013). Endotoxin-free protein production\u2014ClearColi\u2122 technology. Nature Publishing Group US New York.","DOI":"10.1038\/nmeth.f.367"},{"key":"5646_CR28","doi-asserted-by":"publisher","first-page":"113283","DOI":"10.1016\/j.intimp.2024.113283","volume":"143","author":"E Sharif","year":"2024","unstructured":"Sharif, E., Nezafat, N., & Mohit, E. (2024). Recombinant ClearColi\u2122-derived outer membrane vesicles as an effective carrier for development of neoepitope-based vaccine candidate against colon carcinoma. International immunopharmacology, 143, 113283. https:\/\/doi.org\/10.1016\/j.intimp.2024.113283","journal-title":"International immunopharmacology"},{"key":"5646_CR29","doi-asserted-by":"publisher","first-page":"127088","DOI":"10.1016\/j.vaccine.2025.127088","volume":"53","author":"E Sharif","year":"2025","unstructured":"Sharif, E., Mobasheri, T., & Mohit, E. (2025). Bioengineered ClearColi\u2122-derived outer membrane vesicles displaying CT26 neoepitopes as potent vaccine adjuvants against colon carcinoma in a preventive mouse model. Vaccine, 53, 127088.","journal-title":"Vaccine"},{"key":"5646_CR30","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1128\/AEM.01941-14","volume":"80","author":"MH Daleke-Schermerhorn","year":"2014","unstructured":"Daleke-Schermerhorn, M. H., Felix, T., Soprova, Z., ten Hagen-Jongman, C. M., Vikstr\u00f6m, D., Majlessi, L., Beskers, J., Follmann, F., De Punder, K., & van Der Wel, N. N. (2014). Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach. Applied and environmental microbiology, 80, 5854\u20135865.","journal-title":"Applied and environmental microbiology"},{"key":"5646_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.publhealth.121208.131051","volume":"31","author":"GA Colditz","year":"2010","unstructured":"Colditz, G. A., & Taylor, P. R. (2010). Prevention Trials: Their Place in How We Understand the Value of Prevention Strategies. Annual Review of Public Health, 31, 105\u2013120. https:\/\/doi.org\/10.1146\/annurev.publhealth.121208.131051","journal-title":"Annual Review of Public Health"},{"key":"5646_CR32","doi-asserted-by":"publisher","first-page":"626463","DOI":"10.3389\/fonc.2021.626463","volume":"11","author":"DW Crews","year":"2021","unstructured":"Crews, D. W., Dombroski, J. A., & King, M. R. (2021). Prophylactic cancer vaccines engineered to elicit specific adaptive immune response. Frontiers in Oncology, 11, 626463.","journal-title":"Frontiers in Oncology"},{"key":"5646_CR33","doi-asserted-by":"crossref","unstructured":"Wong, K. K., Li, W. A., Mooney, D. J., & Dranoff, G. Chapter Five - Advances in Therapeutic Cancer Vaccines, in: R.D. Schreiber (Ed.) Advances in Immunology, Academic Press2016, pp. 191\u2013249.","DOI":"10.1016\/bs.ai.2015.12.001"},{"key":"5646_CR34","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00284-021-02414-y","volume":"78","author":"E Sharif","year":"2021","unstructured":"Sharif, E., Eftekhari, Z., & Mohit, E. (2021). The effect of growth stage and isolation method on properties of ClearColi\u2122 outer membrane vesicles (OMVs). Current Microbiology, 78, 1602\u20131614.","journal-title":"Current Microbiology"},{"key":"5646_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1089\/vim.2013.0001","volume":"26","author":"K Kaminaka","year":"2013","unstructured":"Kaminaka, K., Matsuda, J., & Nozaki, C. (2013). Influenza virus M2e with additional cysteine residues shows enhanced immunogenicity and protection against lethal virus challenge. Viral immunology, 26, 291\u2013295.","journal-title":"Viral immunology"},{"key":"5646_CR36","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.vaccine.2018.05.113","volume":"36","author":"MR Pulido","year":"2018","unstructured":"Pulido, M. R., Garc\u00eda-Quintanilla, M., Pach\u00f3n, J., & McConnell, M. J. (2018). Immunization with lipopolysaccharide-free outer membrane complexes protects against Acinetobacter baumannii infection. Vaccine, 36, 4153\u20134156.","journal-title":"Vaccine"},{"key":"5646_CR37","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1073\/pnas.0805532107","volume":"107","author":"DJ Chen","year":"2010","unstructured":"Chen, D. J., Osterrieder, N., Metzger, S. M., Buckles, E., Doody, A. M., DeLisa, M. P., & Putnam, D. (2010). Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proceedings of the National Academy of Sciences, 107, 3099\u20133104.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"5646_CR38","doi-asserted-by":"publisher","first-page":"117693512311651","DOI":"10.1177\/11769351231165181","volume":"22","author":"D Brough","year":"2023","unstructured":"Brough, D., Amos, H., Turley, K., & Murkin, J. (2023). Trends in Subcutaneous Tumour Height and Impact on Measurement Accuracy. Cancer Informatics, 22, 11769351231165181. https:\/\/doi.org\/10.1177\/11769351231165181","journal-title":"Cancer Informatics"},{"key":"5646_CR39","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1038\/cti.2014.29","volume":"4","author":"RS Cross","year":"2015","unstructured":"Cross, R. S., Malaterre, J., Davenport, A. J., Carpinteri, S., Anderson, R. L., Darcy, P. K., & Ramsay, R. G. (2015). Therapeutic DNA vaccination against colorectal cancer by targeting the MYB oncoprotein. Clinical & translational immunology, 4, e30.","journal-title":"Clinical & translational immunology"},{"key":"5646_CR40","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/s41591-020-0995-0","volume":"26","author":"JA Juno","year":"2020","unstructured":"Juno, J. A., Tan, H. X., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K., Esterbauer, R., Kent, H. E., Batten, C. J., & Mordant, F. L. (2020). Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nature medicine, 26, 1428\u20131434.","journal-title":"Nature medicine"},{"key":"5646_CR41","doi-asserted-by":"publisher","first-page":"2400770","DOI":"10.1002\/smll.202400770","volume":"20","author":"P Ji","year":"2024","unstructured":"Ji, P., Wu, P., Wang, L., Wang, Y., Guo, X., Gao, R., Guo, Z., Zhou, H., Liu, Z., & Liang, Y. (2024). Lysosome-targeting bacterial outer membrane vesicles for tumor specific degradation of PD\u2010L1. Small (Weinheim An Der Bergstrasse, Germany), 20, 2400770.","journal-title":"Small (Weinheim An Der Bergstrasse, Germany)"},{"key":"5646_CR42","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nri3839","volume":"15","author":"I Voskoboinik","year":"2015","unstructured":"Voskoboinik, I., Whisstock, J. C., & Trapani, J. A. (2015). Perforin and granzymes: function, dysfunction and human pathology. Nature Reviews Immunology, 15, 388\u2013400. https:\/\/doi.org\/10.1038\/nri3839","journal-title":"Nature Reviews Immunology"},{"key":"5646_CR43","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00262-020-02729-y","volume":"70","author":"KL Lee","year":"2021","unstructured":"Lee, K. L., Schlom, J., & Hamilton, D. H. (2021). Combination therapies utilizing neoepitope-targeted vaccines. Cancer Immunology Immunotherapy, 70, 875\u2013885. https:\/\/doi.org\/10.1007\/s00262-020-02729-y","journal-title":"Cancer Immunology Immunotherapy"},{"key":"5646_CR44","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/cancers15133328","volume":"15","author":"E Caproni","year":"2023","unstructured":"Caproni, E., Corbellari, R., Tomasi, M., Isaac, S. J., Tamburini, S., Zanella, I., Grigolato, M., Gagliardi, A., Benedet, M., Baraldi, C., Croia, L., Di Lascio, G., Berti, A., Valensin, S., Bellini, E., Parri, M., Grandi, A., & Grandi, G. (2023). Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles. Cancers, 15, 3328.","journal-title":"Cancers"},{"key":"5646_CR46","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.actbio.2020.03.030","volume":"108","author":"W Huang","year":"2020","unstructured":"Huang, W., Shu, C., Hua, L., Zhao, Y., Xie, H., Qi, J., Gao, F., Gao, R., Chen, Y., & Zhang, Q. (2020). Modified bacterial outer membrane vesicles induce autoantibodies for tumor therapy. Acta biomaterialia, 108, 300\u2013312.","journal-title":"Acta biomaterialia"},{"key":"5646_CR47","doi-asserted-by":"publisher","first-page":"6813","DOI":"10.2147\/IJN.S143264","volume":"12","author":"S Wang","year":"2017","unstructured":"Wang, S., Huang, W., Li, K., Yao, Y., Yang, X., Bai, H., Sun, W., Liu, C., & Ma, Y. (2017). Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor. International Journal of Nanomedicine, 12, 6813\u20136825. https:\/\/doi.org\/10.2147\/IJN.S143264","journal-title":"International Journal of Nanomedicine"},{"key":"5646_CR48","doi-asserted-by":"publisher","first-page":"106749","DOI":"10.1016\/j.micpath.2024.106749","volume":"193","author":"L Sadeghi","year":"2024","unstructured":"Sadeghi, L., Bolhassani, A., Mohit, E., Baesi, K., Aghasadeghi, M. R., Milani, A., & Agi, E. (2024). Engineered ClearColi\u2122-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate. Microbial Pathogenesis, 193, 106749.","journal-title":"Microbial Pathogenesis"},{"key":"5646_CR49","doi-asserted-by":"publisher","unstructured":"Galen,J. E., & Pham, T. (2022). Engineering new immunotherapies against cancer using bacterial outer membrane vesicles and supported by preclinical data. Medical Research Archives, 10. https:\/\/doi.org\/10.18103\/mra.v10i7.2895","DOI":"10.18103\/mra.v10i7.2895"},{"key":"5646_CR50","doi-asserted-by":"publisher","unstructured":"Abe, S., Nagata, H., Crosby, E. J., Inoue, Y., Kaneko, K., Liu, C. X., Yang, X., Wang, T., Acharya, C. R., Agarwal, P., Snyder, J., Gwin, W., Morse, M. A., Zhong, P., Lyerly, H. K., & Osada, T. (2022). Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity. Journal For Immunotherapy Of Cancer, 10. https:\/\/doi.org\/10.1136\/jitc-2021-003717","DOI":"10.1136\/jitc-2021-003717"},{"key":"5646_CR51","doi-asserted-by":"publisher","first-page":"101405","DOI":"10.1016\/j.tranon.2022.101405","volume":"20","author":"T Rupp","year":"2022","unstructured":"Rupp, T., Genest, L., Babin, D., Legrand, C., Hunault, M., Froget, G., & Castagn\u00e9, V. (2022). Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response. Translational oncology, 20, 101405.","journal-title":"Translational oncology"},{"key":"5646_CR52","doi-asserted-by":"publisher","first-page":"2002085","DOI":"10.1002\/adma.202002085","volume":"32","author":"S Qing","year":"2020","unstructured":"Qing, S., Lyu, C., Zhu, L., Pan, C., Wang, S., Li, F., Wang, J., Yue, H., Gao, X., & Jia, R. (2020). Biomineralized bacterial outer membrane vesicles potentiate safe and efficient tumor microenvironment reprogramming for anticancer therapy. Advanced Materials, 32, 2002085.","journal-title":"Advanced Materials"},{"key":"5646_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.fmre.2021.11.032","volume":"2","author":"J Liang","year":"2022","unstructured":"Liang, J., Cheng, K., Li, Y., Xu, J., Chen, Y., Ma, N., Feng, Q., Zhu, F., Ma, X., Zhang, T., Yue, Y., Liu, G., Guo, X., Chen, Z., Wang, X., Zhao, R., Zhao, Y., Shi, J., Zhao, X., & Nie, G. (2022). Personalized cancer vaccines from bacteria-derived outer membrane vesicles with antibody-mediated persistent uptake by dendritic cells. Fundamental Research, 2, 23\u201336. https:\/\/doi.org\/10.1016\/j.fmre.2021.11.032","journal-title":"Fundamental Research"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05646-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05646-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05646-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:30:51Z","timestamp":1782099051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05646-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5646"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05646-5","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"24 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In vivo experiments received approval from the research ethics committee of the faculty of pharmacy at Shahid Beheshti University of Medical Sciences, Tehran, Iran (ID IR.SBMU.AEC.1403.100), and were conducted in accordance with ethical guidelines and international standards for laboratory animal research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Our research involves no human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Our manuscript contains no individual person\u2019s data in any form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}